Literature DB >> 27094322

Value-Based Hypothesis Testing for Cardiac Device Clinical Trials: A Pathway for Accelerated Reimbursement Decisions.

Donald E Cutlip1, Daniel B Kramer2.   

Abstract

Entities:  

Keywords:  Centers for Medicare and Medicaid Services (US); United States Food and Drug Administration; clinical trial; healthcare costs

Mesh：

Year:  2016        PMID： 27094322      PMCID： PMC4995447          DOI： 10.1161/CIRCINTERVENTIONS.116.003627

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN： 1941-7640            Impact factor:   6.546


× No keyword cloud information.
  12 in total

1.  Valuation of EuroQOL (EQ-5D) health states in an adult US sample.

Authors:  J A Johnson; S J Coons; A Ergo; G Szava-Kovats
Journal:  Pharmacoeconomics       Date:  1998-04       Impact factor: 4.981

2.  What is value in health care?

Authors:  Michael E Porter
Journal:  N Engl J Med       Date:  2010-12-08       Impact factor: 91.245

Review 3.  Sacubitril-Valsartan for the Treatment of Heart Failure: Effectiveness and Value.

Authors:  Daniel A Ollendorf; Alexander T Sandhu; Steven D Pearson
Journal:  JAMA Intern Med       Date:  2016-02       Impact factor: 21.873

4.  Medicare and cost-effectiveness analysis.

Authors:  Peter J Neumann; Allison B Rosen; Milton C Weinstein
Journal:  N Engl J Med       Date:  2005-10-06       Impact factor: 91.245

5.  Cost-reducing innovation in health care.

Authors:  James C Robinson; Mark D Smith
Journal:  Health Aff (Millwood)       Date:  2008 Sep-Oct       Impact factor: 6.301

6.  Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles: A Consensus Document From the Mitral Valve Academic Research Consortium.

Authors:  Gregg W Stone; Alec S Vahanian; David H Adams; William T Abraham; Jeffrey S Borer; Jeroen J Bax; Joachim Schofer; Donald E Cutlip; Mitchell W Krucoff; Eugene H Blackstone; Philippe Généreux; Michael J Mack; Robert J Siegel; Paul A Grayburn; Maurice Enriquez-Sarano; Patrizio Lancellotti; Gerasimos Filippatos; Arie Pieter Kappetein
Journal:  J Am Coll Cardiol       Date:  2015-07-21       Impact factor: 24.094

7.  Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery.

Authors:  David J Cohen; Ben Van Hout; Patrick W Serruys; Friedrich W Mohr; Carlos Macaya; Peter den Heijer; M M Vrakking; Kaijun Wang; Elizabeth M Mahoney; Salma Audi; Katrin Leadley; Keith D Dawkins; A Pieter Kappetein
Journal:  N Engl J Med       Date:  2011-03-17       Impact factor: 91.245

8.  Effect of PCI on quality of life in patients with stable coronary disease.

Authors:  William S Weintraub; John A Spertus; Paul Kolm; David J Maron; Zefeng Zhang; Claudine Jurkovitz; Wei Zhang; Pamela M Hartigan; Cheryl Lewis; Emir Veledar; Jim Bowen; Sandra B Dunbar; Christi Deaton; Stanley Kaufman; Robert A O'Rourke; Ron Goeree; Paul G Barnett; Koon K Teo; William E Boden; G B J Mancini
Journal:  N Engl J Med       Date:  2008-08-14       Impact factor: 91.245

9.  Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.

Authors:  David J Cohen; Ameet Bakhai; Chunxue Shi; Louise Githiora; Tara Lavelle; Ronna H Berezin; Martin B Leon; Jeffrey W Moses; Joseph P Carrozza; James P Zidar; Richard E Kuntz
Journal:  Circulation       Date:  2004-07-19       Impact factor: 29.690

10.  Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction).

Authors:  Eldrin F Lewis; Yanhong Li; Marc A Pfeffer; Scott D Solomon; Kevin P Weinfurt; Eric J Velazquez; Robert M Califf; Jean-Lucien Rouleau; Lars Kober; Harvey D White; Kevin A Schulman; Shelby D Reed
Journal:  JACC Heart Fail       Date:  2014-04       Impact factor: 12.035
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.